Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Reteplase, trade names include Retavase, is a thrombolytic drug, used to treat heart attacks by breaking up the clots that cause them.
Art & Overview
Explore the main themes, entities and connections around Reteplase. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
clots alteplase recombinant human tissue plasminogen activator penetrate trade names retavase protein bacterium half-life fibrin include thrombolytic drug used treat
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Reteplase | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Reteplase | ATC code | B01AD07 (WHO) | 1.00 | infobox |
| Reteplase | CAS Number | 133652-38-7 Y | 1.00 | infobox |
| Reteplase | ChemSpider | none | 1.00 | infobox |
| Reteplase | DrugBank | DB00015 Y | 1.00 | infobox |
| Reteplase | Formula | C1736H2671N499O522S22 | 1.00 | infobox |
| Reteplase | KEGG | D05721 Y | 1.00 | infobox |
| Reteplase | License data | EU EMA: by INN | 1.00 | infobox |
| Reteplase | Molar mass | 39589.75 g·mol−1 | 1.00 | infobox |
| Reteplase | Trade names | Retavase, Retefuse, Rapilysin, Mirel, others | 1.00 | infobox |
| Reteplase | UNII | DQA630RIE9 | 1.00 | infobox |
| Reteplase | is a | recombinant non-glycosylated form of human tissue plasminogen activator | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.